Esketamine in Treatment-Resistant Depression: Clinical and Translational Perspectives
{{output}}
Background: Esketamine, an intranasally administered N-methyl-D-aspartate (NMDA) receptor antagonist, represents a significant advancement in the treatment of Major Depressive Disorder (MDD), particularly among patients with Trea... ...
